IO Biotech Inc. (NASDAQ: IOBT) Stock Information | RedChip

IO Biotech Inc. (NASDAQ: IOBT) Listen to this Section


$1.39
+0.0400 ( +2.96% ) 76.2K

IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.

Market Data


Open


$1.39

Previous close


$1.35

Volume


76.2K

Market cap


$92.23M

Day range


$1.35 - $1.45

52 week range


$0.82 - $2.12

Insider Ownership Transactions

Total Amount Purchased: -14,630,618.00 | $ -20,336,559.02

Date Type Amount Purchased Purchaser
2024-03-18 Sale -185000.00 Smith Devin Whittemore
2024-03-18 Sale -50000.00 Burkavage Brian
2024-03-18 Sale -280000.00 Ahmad Qasim Iftikhar
2024-02-13 Sale -658809.00 Novo Holdings A/S
2023-11-24 Buy 5000.00 Burkavage Brian
2023-11-17 Sale -64238.00 Collins Helen Louise
2023-08-15 Sale -64238.00 Hunter Heidi
2023-08-11 Buy 2469135.00 Novo Holdings A/S
2023-08-11 Sale -7901234.00 Lundbeckfond Invest A/S
2023-08-11 Sale -7901234.00 Elling Christian E

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 May 14, 2024
10-q Quarterly Reports 64 May 14, 2024
8-k 8K-related 15 May 14, 2024
8-k 8K-related 13 Apr 26, 2024
ars Annual reports 1 Apr 24, 2024
def Proxies and info statements 5 Apr 24, 2024
10-k/a Quarterly Reports 17 Mar 22, 2024
4 Insider transactions 1 Mar 18, 2024
4 Insider transactions 1 Mar 18, 2024
4 Insider transactions 1 Mar 18, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.